Source disclosure: February 06, 2026
OncoTherapy Science,Inc. [4564.T]
TOKYO, Feb 06 (Pulse News Wire) – Oncotherapy Science,inc. (4564.T) reported non-operating expenses for the third quarter of its fiscal year ending March 2026.
The company recorded issuance costs related to the distribution of shares resulting from the exercise of warrants amounting to ¥23 million. In addition, OncoTherapy Science stated that while it has yet to disclose its full-year forecast for the fiscal year ending March 2026, it intends to update stakeholders once more information becomes available.
Management remains committed to providing timely updates on the company's financial performance and strategic initiatives. Investors are advised to monitor future communications for further developments.
AI-translated content. 🟢 Confidence: High See terms • Original filing